Results 181 to 190 of about 13,525 (233)

Diphenylhydantoin Gingival Hyperplasia

Archives of Pediatrics & Adolescent Medicine, 1969
DIPHENYLHYDANTOIN (Dilantin) sodium was synthesized in 1908 by Biltz1and introduced as an antiepileptic agent in 1938 by Merritt and Putnam.2Extensive subsequent use of this drug has confirmed its efficacy in controlling epileptic seizures, particularly major motor (grand mal) convulsions.
H L, Livingston, S, Livingston
openaire   +3 more sources

Nifedipine-Induced Gingival Hyperplasia

Drug Intelligence & Clinical Pharmacy, 1986
Gingival hyperplasia, a condition characterized by increased amounts of gingival connective tissue, has most commonly been observed in patients receiving phenytoin, but has also been noted in patients receiving cyclosporine and, as in this case report, nifedipine.
A A, Shaftic, L L, Widdup, M A, Abate, A I, Jacknowitz   +3 more
openaire   +2 more sources

[Gingival hyperplasia].

Medizinische Monatsschrift fur Pharmazeuten, 2010
Gingival hyperplasia is a typical adverse reaction of certain drugs (phenytoin, calcium antagonists and cyclosporine). Also oral contraceptives and presumably hormone replacement therapy may rarely lead to gingival hyperplasia. By differential diagnosis a paraneoplastic syndrome has to be taken into account.
Christiane, De Rop, Gesine, Picksak, Dirk O, Stichtenoth   +2 more
openaire   +1 more source

Incidence of diphenylhydantoin gingival hyperplasia

Oral Surgery, Oral Medicine, Oral Pathology, 1972
Abstract The incidence of diphenylhydantoin gingival hyperplasia was studied in 173 hospitalized patients who were mainly middle aged and older. The incidence in this series was found to be 53.2 per cent; it was related to the degree of the patients' oral hygiene, while the age, sex, daily dosage of diphenylhydantoin medication, and duration of ...
A P, Angelopoulos, P W, Goaz
openaire   +2 more sources

Localized juvenile spongiotic gingival hyperplasia

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2008
We report 52 cases of a unique and pathologically distinctive form of inflammatory gingival hyperplasia in young patients. Clinically, the average age of patients in this study was 11.8 years, with a 2.3:1 female predominance. Caucasians comprised 77% of the cases, and nearly all of the lesions were located on the anterior gingiva, with 81% affecting ...
Julia Yu Fong, Chang, Harvey P, Kessler, John M, Wright   +2 more
openaire   +2 more sources

Tacrolimus-Induced Gingival Hyperplasia

JCR: Journal of Clinical Rheumatology, 2023
Eaman, Alhassan, Lamees, Al-Hassan
openaire   +2 more sources

[Gingival hyperplasia caused by nifedipine].

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1986
Fifty patients receiving nifedipine have been observed for the presence of gingival hyperplasia. Thirty were males and 20 females, the mean age was 57.7 ± 14.5 years. The duration of therapy with Nifedipine at the time of dermatological examination was 18.25 ± 16 months (min. 2, max. 48).
P. L. Bencini, C. Crosti, F. Sala, G. C. Ambroso, D. Marini   +4 more
openaire   +2 more sources

HEREDITARY GENERAL GINGIVAL HYPERPLASIA

Journal of Heredity, 1950
S M, GARN, C E, HATCH
openaire   +2 more sources

Nifedipine-induced gingival hyperplasia.

The Journal of the Tennessee Dental Association, 1992
Gingial hyperplasia is a complication which may be seen in a significant number of patients taking nifedipine (Procardia, Pfizer) a commonly used medication for cardiac vessel dilitation. This is a report of gingival changes in a 43-year-old hypertensive male who began using the calcium channel blocking agent during his active dental treatment ...
E J, Burkes, J R, Jacoway, D T, Stevens, M E, Braddock   +3 more
openaire   +1 more source

Gingival Hyperplasia and Diphenylhydantoin

Journal of Periodontology, 1972
S G, Ciancio, S J, Yaffe, C C, Catz
openaire   +2 more sources